Astellas Pharma Inc 2016 SR
The report outlines Astellas Pharma's environmental performance for fiscal 2015, highlighting a 30.8% reduction in global greenhouse gas emissions compared to the 2005 base year. The company achieved its targets for water withdrawal reduction, reaching 76.3% of 2005 levels, and maintained a waste landfill rate below 1% in Japan. Significant progress was made in biodiversity initiatives, with the Biodiversity Index reaching 3.18 times the 2005 level. Additionally, the report details the transition to renewable energy sources at several overseas plants and the implementation of a global EHS management system.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2016
Type: SR
Pages: 39
Astellas Pharma Inc
The report outlines Astellas Pharma's environmental performance for fiscal 2015, highlighting a 30.8% reduction in global greenhouse gas emissions compared to the 2005 base year. The company achieved its targets for water withdrawal reduction, reaching 76.3% of 2005 levels, and maintained a waste landfill rate below 1% in Japan. Significant progress was made in biodiversity initiatives, with the Biodiversity Index reaching 3.18 times the 2005 level. Additionally, the report details the transition to renewable energy sources at several overseas plants and the implementation of a global EHS management system.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2015 - Mar 31, 2016
Fiscal Year
2015
Published
Jun 1, 2016
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Employees